Grifols (GIFLF) Gross Profit (2010 - 2025)
Grifols' (GIFLF) quarterly Gross Profit came in at $3.3 billion in Q4 2025, up 11.47% on a YoY basis from $3.0 billion in Q4 2024, and up 11.47% quarter-over-quarter from $3.0 billion in Q4 2024.
Analysis
Grifols (GIFLF) Gross Profit (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Gross Profit for 14 consecutive years, with $3.3 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 11.47% year-over-year to $3.3 billion; the trailing twelve-month figure through Dec 2025 stood at $6.3 billion (up 74.0% YoY), and the FY2025 full-year result was $3.2 billion, up 8.19% from the prior year.
- Gross Profit grew to $3.3 billion in Q4 2025 per GIFLF's latest filing, from $3.0 billion in the prior quarter.
- Across five years, Gross Profit topped out at $3.3 billion in Q4 2025 and bottomed at -$11.1 million in Q4 2021.
- Historically, Gross Profit has averaged $2.1 billion across 3 years, with a median of $3.0 billion in 2024.
- The sharpest annual moves came in 2021 and 2025: Gross Profit increased 5.38% in 2021, then climbed 11.47% in 2025.
- Over 3 years, Gross Profit stood at -$11.1 million in 2021, then surged by 26945.35% to $3.0 billion in 2024, then gained by 11.47% to $3.3 billion in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $3.3 billion, $3.0 billion, and -$11.1 million for Q4 2025, Q4 2024, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.33 Bn |
| Dec 31, 2024 | 2.99 Bn |
| Dec 31, 2021 | -11.12 Mn |
| Dec 31, 2020 | -11.75 Mn |
| Mar 31, 2020 | 652.69 Mn |
| Dec 31, 2019 | 1.92 Bn |
| Mar 31, 2019 | 600.20 Mn |
| Dec 31, 2018 | 1.75 Bn |
| Jun 30, 2018 | 617.52 Mn |
| Mar 31, 2018 | 600.55 Mn |
| Dec 31, 2017 | 1.92 Bn |
| Jun 30, 2017 | 617.18 Mn |
| Mar 31, 2017 | 577.34 Mn |
| Dec 31, 2016 | 542.60 Mn |
| Sep 30, 2016 | 522.27 Mn |
| Jun 30, 2016 | 535.76 Mn |
| Mar 31, 2016 | 878.52 Mn |
| Dec 31, 2015 | 571.74 Mn |
| Sep 30, 2015 | 536.77 Mn |
| Jun 30, 2015 | 525.73 Mn |